Disclosures for "Metabolomic Profiling of Plasma Samples from PPMI Identifies Molecular Signatures of Parkinson’s Disease and Genetic Parkinson’s Disease Susceptibility")
-
Dr. Huntwork-Rodriguez has received personal compensation for serving as an employee of Denali Therapeutics. Dr. Huntwork-Rodriguez has received stock or an ownership interest from Denali Therapeutics. Dr. Huntwork-Rodriguez has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Suh has received personal compensation for serving as an employee of Denali Therapeutics .
-
The institution of Dr. Crotty has received research support from Parkinson's Foundation.
-
Mr. Maciuca has received personal compensation for serving as an employee of Denali Therapeutics. Mr. Maciuca has received stock or an ownership interest from Denali Therapeutics.
-
Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson Healthcare LLC. Dr. Macklin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Macklin has received research support from Amylyx Pharmaceuticals. The institution of Dr. Macklin has received research support from Biohaven. The institution of Dr. Macklin has received research support from Clene Nanomedicine. The institution of Dr. Macklin has received research support from GlaxoSmithKline. The institution of Dr. Macklin has received research support from Mitsubishi Tanabe. The institution of Dr. Macklin has received research support from Prilenia. The institution of Dr. Macklin has received research support from Ra Pharmaceuticals.
-
Dr. Davis has received personal compensation for serving as an employee of Denali Therapeutics.
-
Mr. Alkabsh has received personal compensation for serving as an employee of Denali Therepeutics.
-
An immediate family member of Rachit Bakshi has received personal compensation for serving as an employee of Partner Therapeutics. The institution of Rachit Bakshi has received research support from MJFF.
-
Dr. Chen has nothing to disclose.
-
Dr. Molsberry has nothing to disclose.
-
The institution of Dr. Ascherio has received research support from NIH and US Department of Defense .
-
Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali Therapeutics. Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chase Therapeutics (indirectly, as a service of the Parkinson Study Group service). Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partner Therapeutics (indirectly, as a service of the Parkinson Study Group service). Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial Biotech (indirectly, as a service of the Parkinson Study Group service). Dr. Schwarzschild has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Schwarzschild has received research support from NIH. The institution of Dr. Schwarzschild has received research support from Parkinson's Foundation. The institution of Dr. Schwarzschild has received research support from Michael J Fox Foundation. The institution of Dr. Schwarzschild has received research support from Farmer Family Foundation. Dr. Schwarzschild has a non-compensated relationship as a Chair, Executive Committee with the Parkinson Study Group that is relevant to AAN interests or activities.